These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19602460)

  • 1. Chromosomal copy number changes of locally advanced rectal cancers treated with preoperative chemoradiotherapy.
    Grade M; Gaedcke J; Wangsa D; Varma S; Beckmann J; Liersch T; Hess C; Becker H; Difilippantonio MJ; Ried T; Ghadimi BM
    Cancer Genet Cytogenet; 2009 Aug; 193(1):19-28. PubMed ID: 19602460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosomal copy number alterations are associated with persistent lymph node metastasis after chemoradiation in locally advanced rectal cancer.
    Chen Z; Liu Z; Deng X; Warden C; Li W; Garcia-Aguilar J
    Dis Colon Rectum; 2012 Jun; 55(6):677-85. PubMed ID: 22595848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy.
    Ghadimi BM; Grade M; Difilippantonio MJ; Varma S; Simon R; Montagna C; Füzesi L; Langer C; Becker H; Liersch T; Ried T
    J Clin Oncol; 2005 Mar; 23(9):1826-38. PubMed ID: 15774776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosomal copy number alterations are associated with tumor response to chemoradiation in locally advanced rectal cancer.
    Chen Z; Liu Z; Li W; Qu K; Deng X; Varma MG; Fichera A; Pigazzi A; Garcia-Aguilar J
    Genes Chromosomes Cancer; 2011 Sep; 50(9):689-99. PubMed ID: 21584903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative chemoradiotherapy and radical surgery for locally advanced distal rectal adenocarcinoma: pathologic findings and clinical implications.
    Medich D; McGinty J; Parda D; Karlovits S; Davis C; Caushaj P; Lembersky B
    Dis Colon Rectum; 2001 Aug; 44(8):1123-8. PubMed ID: 11535851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.
    Hong YS; Nam BH; Kim KP; Kim JE; Park SJ; Park YS; Park JO; Kim SY; Kim TY; Kim JH; Ahn JB; Lim SB; Yu CS; Kim JC; Yun SH; Kim JH; Park JH; Park HC; Jung KH; Kim TW
    Lancet Oncol; 2014 Oct; 15(11):1245-53. PubMed ID: 25201358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
    Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
    Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial.
    Lee JB; Kim HS; Jung I; Shin SJ; Beom SH; Chang JS; Koom WS; Kim TI; Hur H; Min BS; Kim NK; Park S; Jeong SY; Baek JH; Kim SH; Lim JS; Lee KY; Ahn JB
    Trials; 2020 Apr; 21(1):320. PubMed ID: 32264919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
    Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C
    J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative chemoradiotherapy in locally advanced rectal cancer: correlation of a gene expression-based response signature with recurrence.
    Liersch T; Grade M; Gaedcke J; Varma S; Difilippantonio MJ; Langer C; Hess CF; Becker H; Ried T; Ghadimi BM
    Cancer Genet Cytogenet; 2009 Apr; 190(2):57-65. PubMed ID: 19380020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A functional biological network centered on XRCC3: a new possible marker of chemoradiotherapy resistance in rectal cancer patients.
    Agostini M; Zangrando A; Pastrello C; D'Angelo E; Romano G; Giovannoni R; Giordan M; Maretto I; Bedin C; Zanon C; Digito M; Esposito G; Mescoli C; Lavitrano M; Rizzolio F; Jurisica I; Giordano A; Pucciarelli S; Nitti D
    Cancer Biol Ther; 2015; 16(8):1160-71. PubMed ID: 26023803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extensive surgery after high-dose preoperative chemoradiotherapy for locally advanced recurrent rectal cancer.
    Rödel C; Grabenbauer GG; Matzel KE; Schick C; Fietkau R; Papadopoulos T; Martus P; Hohenberger W; Sauer R
    Dis Colon Rectum; 2000 Mar; 43(3):312-9. PubMed ID: 10733111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of preoperative radiation plus concurrent daily tegafur-uracil (UFT) with leucovorin for locally advanced rectal cancer.
    Cellier P; Leduc B; Martin L; Vié B; Chevelle C; Vendrely V; Salemkour A; Carrie C; Calais G; Burtin P; Campion L; Boisdron-Celle M; Morel A; Berger V; Gamelin E
    BMC Cancer; 2011 Mar; 11():98. PubMed ID: 21410976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic implications of the distribution of lymph node metastases in rectal cancer after neoadjuvant chemoradiotherapy.
    Leibold T; Shia J; Ruo L; Minsky BD; Akhurst T; Gollub MJ; Ginsberg MS; Larson S; Riedel E; Wong WD; Guillem JG
    J Clin Oncol; 2008 May; 26(13):2106-11. PubMed ID: 18362367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of preoperative chemoradiotherapy on the number of lymph nodes retrieved in rectal cancer.
    Ha YH; Jeong SY; Lim SB; Choi HS; Hong YS; Chang HJ; Kim DY; Jung KH; Park JG
    Ann Surg; 2010 Aug; 252(2):336-40. PubMed ID: 20647928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of adjuvant chemotherapy in locally advanced rectal cancer with ypT0-3N0 after preoperative chemoradiation therapy and surgery.
    Kim CG; Ahn JB; Shin SJ; Beom SH; Heo SJ; Park HS; Kim JH; Choe EA; Koom WS; Hur H; Min BS; Kim NK; Kim H; Kim C; Jung I; Jung M
    BMC Cancer; 2017 Sep; 17(1):615. PubMed ID: 28865435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study.
    Molinari C; Ballardini M; Teodorani N; Giannini M; Zoli W; Emiliani E; Lucci E; Passardi A; Rosetti P; Saragoni L; Guidoboni M; Amadori D; Calistri D
    Radiat Oncol; 2011 Nov; 6():161. PubMed ID: 22099067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific c-K-ras gene mutations as a tumor-response marker in locally advanced rectal cancer treated with preoperative chemoradiotherapy.
    Luna-Pérez P; Segura J; Alvarado I; Labastida S; Santiago-Payán H; Quintero A
    Ann Surg Oncol; 2000 Dec; 7(10):727-31. PubMed ID: 11129419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade.
    Wheeler JM; Dodds E; Warren BF; Cunningham C; George BD; Jones AC; Mortensen NJ
    Dis Colon Rectum; 2004 Dec; 47(12):2025-31. PubMed ID: 15657650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant chemoradiotherapy of advanced resectable rectal cancer: results of a randomised trial comparing modulation of 5-fluorouracil with folinic acid or with interferon-α.
    Kornmann M; Staib L; Wiegel T; Kreuser ED; Kron M; Baumann W; Henne-Bruns D; Link KH
    Br J Cancer; 2010 Oct; 103(8):1163-72. PubMed ID: 20877353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.